BLS vs OCC

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BLS

BLSPHARMA FPO [BLS]

56MEDIUM

OCC

ORTHOCELL FPO [OCC]

51MEDIUM

Score Breakdown

BLS OCC
Technical
49
49
Catalyst
55
51
Sentiment
50
50
Fundamental
96
83
Momentum
84
47
Risk Gate
50
45

Key Metrics

BLS Metric OCC
$193.2MMarket Cap$196.1M
218KAvg Volume (20d)515K
+0.0%Short Interest+0.4%
$1.10052-Week High$1.600
$0.33052-Week Low$0.700
+1.8%Daily Change+0.7%
$0.855Reference Price$0.720
+66.1%ROE-41.1%
+18.7%Profit Margin-133.8%

Active Signals

BLS Signals

MACD momentum is losing steam
Drifting lower — down 8.1% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Low P/S ratio (4.0x)
Strong revenue growth (+150%)
Piotroski F-Score strong (8/9, low-confidence approx)

OCC Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Death cross triggered — the short-term trend just crossed below the long-term, which is a bearish signal
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 3.4% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare BLS and OCC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs PAR →BLS vs PCK →BLS vs PIQ →BLS vs RHY →BLS vs VIT →
BLS Full Analysis → OCC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).